Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 12, Number 7, September 2012

Articles

Targeted Therapy of Multiple Myeloma: The Changing Paradigm at the Beginning of the New Millennium
pp. 743-756(14)
Authors: Morabito, Fortunato; Grazia Recchia, Anna; Mazzone, Carla; Gentile, Massimo

Favourites:
ADD

Molecular Targets for the Treatment of Multiple Myeloma
pp. 757-767(11)
Authors: Rossi, Marco; Teresa Di Martino, Maria; Morelli, Eugenio; Leotta, Marzia; Rizzo, Antonietta; Grimaldi, Anna; Misso, Gabriella; Tassone, Pierfrancesco; Caraglia, Michele

Favourites:
ADD

Antiangiogenic Therapeutic Approaches in Multiple Myeloma
pp. 768-775(8)
Authors: Ribatti, Domenico; Mangialardi, Giuseppe; Vacca, Angelo

Favourites:
ADD

Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma
pp. 776-796(21)
Authors: Neri, Paola; J. Bahlis, Nizar

Favourites:
ADD
Favourites:
ADD

Open Access Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
pp. 814-822(9)
Authors: Tassone, P.; Neri, P.; Burger, R.; T. Di Martino, M.; Leone, E.; Amodio, N.; Caraglia, M.; Tagliaferri, P.

Favourites:
ADD

MicroRNAs in the Pathobiology of Multiple Myeloma
pp. 823-837(15)
Authors: Lionetti, Marta; Agnelli, Luca; Lombardi, Luigia; Tassone, Pierfrancesco; Neri, Antonino

Favourites:
ADD

Open Access Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
pp. 838-846(9)
Authors: Tagliaferri, P.; Rossi, M.; T. Di Martino, M.; Amodio, N.; Leone, E.; Gulla, A.; Neri, A.; Tassone, P.

Favourites:
ADD

Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells
pp. 847-856(10)
Authors: Koike, K.; Ueda, Y.; Hase, H.; Kitae, K.; Fusamae, Y.; Masai, S.; Inagaki, T.; Saigo, Y.; Hirasawa, S.; Nakajima, K.; Ohshio, I.; Makino, Y.; Konishi, N.; Yamamoto, H.; Tsujikawa, K.

Favourites:
ADD

Open Access A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
pp. 857-872(16)
Authors: Mihaly, Z.; Sztupinszki, Z.; Surowiak, P.; Gyorffy, B.

Favourites:
ADD

A Molecular Signature for Oncogenic BRAF in Human Colon Cancer Cells is Revealed by Microarray Analysis
pp. 873-898(26)
Authors: Joyce, T.; Oikonomou, E.; Kosmidou, V.; Makrodouli, E.; Bantounas, I.; Avlonitis, S.; Zografos, G.; Pintzas, A.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more